Validation of a Sensitive Flow Cytometry Assay to Assess Minimal Residual Disease of Multiple Myeloma Cells in Apheresis Product

被引：0
|
作者：
Jones, Nicholas [1 ]
Ragheb, Josette William [2 ]
Ngo, Brian [1 ]
Uyeji, David [2 ]
Hii, Anselm L. [2 ]
机构：
[1] NeoGen Labs Inc, Pharma Serv, Aliso Viejo, CA USA
[2] NeoGen Labs Inc, Aliso Viejo, CA USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-119858
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5646
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Monitoring of minimal residual disease in multiple myeloma:: Flow cytometry vs PCR-based techniques
    Lioznov, M.
    Badbaran, A.
    Fehse, B.
    Zander, A.
    Kroeger, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 203 - 203
  • [22] An analysis of the false negative rate of minimal residual disease measurement by multiparameter flow cytometry in multiple myeloma
    Austin, Michael
    O'Connor, Simon
    Morilla, Ricardo
    Pawlyn, Charlotte
    Kaiser, Martin F.
    Boyd, Kevin D.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2020, 42 (02) : E65 - E67
  • [23] Minimal Residual Disease By Flow Cytometry in Multiple Myeloma Based on Euro-Flow Panel in Patients with Clinical Remission of the Disease
    Carrasco-Yalan, Antonio
    Pando-Mayta, John W.
    Soto-Delgado, Tania
    Obregon-Zegarra, Eva H.
    Valdes-Gomez, Jorge J.
    Cuyutupac-Barja, Marylin
    Castillo-Aguirre, Jorge F.
    Guevara-Canales, Jose M.
    BLOOD, 2017, 130
  • [24] Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
    Flores-Montero, J.
    Sanoja-Flores, L.
    Paiva, B.
    Puig, N.
    Garcia-Sanchez, O.
    Boettcher, S.
    van der Velden, V. H. J.
    Perez-Moran, J-J
    Vidriales, M-B
    Garcia-Sanz, R.
    Jimenez, C.
    Gonzalez, M.
    Martinez-Lopez, J.
    Corral-Mateos, A.
    Grigore, G-E
    Fluxa, R.
    Pontes, R.
    Caetano, J.
    Sedek, L.
    del Canizo, M-C
    Blade, J.
    Lahuerta, J-J
    Aguilar, C.
    Barez, A.
    Garcia-Mateo, A.
    Labrador, J.
    Leoz, P.
    Aguilera-Sanz, C.
    San-Miguel, J.
    Mateos, M-V
    Durie, B.
    van Dongen, J. J. M.
    Orfao, A.
    LEUKEMIA, 2017, 31 (10) : 2094 - 2103
  • [25] Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
    J Flores-Montero
    L Sanoja-Flores
    B Paiva
    N Puig
    O García-Sánchez
    S Böttcher
    V H J van der Velden
    J-J Pérez-Morán
    M-B Vidriales
    R García-Sanz
    C Jimenez
    M González
    J Martínez-López
    A Corral-Mateos
    G-E Grigore
    R Fluxá
    R Pontes
    J Caetano
    L Sedek
    M-C del Cañizo
    J Bladé
    J-J Lahuerta
    C Aguilar
    A Bárez
    A García-Mateo
    J Labrador
    P Leoz
    C Aguilera-Sanz
    J San-Miguel
    M-V Mateos
    B Durie
    J J M van Dongen
    A Orfao
    Leukemia, 2017, 31 : 2094 - 2103
  • [26] The Prognostic Role and Utility of Highly Sensitive Minimal Residual Disease Assay in Multiple Myeloma: Is There Really a Difference?
    Fonseca, Rodrigo
    Wiedmeier, Julia E.
    Arribas, Mariano
    Fonseca, Rafael
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S420 - S420
  • [27] Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myeloma
    Dold, Sandra Maria
    Riebl, Veronika
    Wider, Dagmar
    Follo, Marie
    Pantic, Milena
    Ihorst, Gabriele
    Duyster, Justus
    Zeiser, Robert
    Waesch, Ralph
    Engelhardt, Monika
    HAEMATOLOGICA, 2020, 105 (10) : E523 - E530
  • [28] MONITORING OF MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA BY A SINGLE-TUBE 10-COLOR FLOW CYTOMETRY
    Shen, Wenhong
    Dai, Lan
    He, Yang
    Zhu, Mingqing
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 : 107 - 107
  • [29] Minimal Residual Disease in Multiple Myeloma
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (20) : 2523 - 2526
  • [30] Minimal residual disease for multiple myeloma
    Avet-Loiseau, Herve
    Corre, Jill
    HEMATOLOGIE, 2019, 25 : 36 - 39
12345